The CRDT offers innovative treatment to treat children who are diagnosed throughout the United States and globally with conditions including:
- Adrenoleukodystrophy
- Alpha-1-Antitrypsin (AT) Deficiency
- Bare Lymphocyte Syndrome (BLS)
- Byler Disease
- Chronic Granulomatous Disease (CGD)
- Chronic Pancreatitis and Acute Recurrent Pancreatitis
- Combined Immune Deficiency (CID) Syndromes
- Combined Variable Immune Deficiency(CVID) Syndrome
- Congenital Corneal Opacity (Peters Anomaly and Sclerocornea)
- Crigler-Najjar syndrome
- Fabry Disease
- Fatty Acid Oxidation Deficiencies
- Gaucher Disease
- Glutaric Acidemia Type 1
- Glycogen Storage Disorders
- GM3 Synthase Deficiency
- Hemophagocytic Lymphohistiocytosis (HLH) Syndromes
- Hereditary Telangiectasia (HHT)
- Hunter Syndrome (MPS-II)
- Hurler Syndrome (MPS-I)
- Krabbe Disease
- Maple Syrup Urine Disease (MSUD)
- Metachromatic Leukodystrophy
- Methylmalonic Acidemia
- Mitochondrial Disorder
- Niemann-Pick Disease Type C
- Phenylketonuria (PKU)
- Pompe Disease
- Progressive Familial Intrahepatic Cholestasis
- Propionic Acidemia
- Severe Combined Immune Deficiency(SCID)
- Urea Cycle Disorders
- Vanishing White Matter Disease